whatsmovingnow

COR

Cencora, Inc.

October 1, 2026 · market open

Rarity
1.29
Peak move
+3.92%
Float cap
$58.0B

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. It distributes brand-name, specialty, generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and equipment to hospitals, health systems, pharmacies, clinics, physician practices, veterinarians, and other providers. It also offers data analytics, consulting, logistics, inventory management, pharmacy automation, and packaging services to healthcare providers and pharmaceutical manufacturers.

Where do you see this going?

no votes yet

Voting closed at 4:00 PM ET.

What we found

6 events · 0 from SEC or newswire · 0 timed with the move
  • Key eventpeer_disclosure

    Cardinal Health entered a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032, retaining the current scope of distribution services.

    Websec.gov
  • Key eventpeer_disclosure

    McKesson is extending its existing pharmaceutical distribution agreement with CVS Health through June 2032 and backed its fiscal-year outlook, projecting adjusted EPS of $44.20-$45.

    Webmarketwatch.com
  • Key eventguidance_change

    Cardinal Health reaffirmed its fiscal 2027 non-GAAP EPS guidance of 13%-15% growth ($12.40-$12.60) and long-term non-GAAP EPS growth of 12%-14% in connection with the CVS Health distribution agreement extension.

    Websec.gov
  • analyst_rating

    Wells Fargo raised its price target on Cencora (COR) to $395 from $331 while maintaining an Overweight rating.

    Webde.investing.com
  • board_change

    Cencora elected Robert E. Sanchez, Executive Chair and former Chairman/CEO of Ryder System, as a new independent director effective October 1, 2026, expanding its board from 10 to 11 seats; he has not yet been named to a committee.

    Webkalkine.comWebmarketwatch.comWebexecutive-moves.comWebwallstreet-online.deWebkalkine.com
  • customer_loss

    Cencora disclosed that certain Walgreens volume serviced outside its prime vendor agreement began moving to rival distributors on July 1, 2026, while the prime vendor agreement covering the vast majority of its Walgreens business remains unchanged.

    Webgurufocus.comWebblog.tipranks.com